Financial reports
10-K
2020 FY
Annual report
16 Mar 21
10-Q
2020 Q3
Quarterly report
9 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-Q
2020 Q1
Quarterly report
27 May 20
10-K
2019 FY
Annual report
16 Mar 20
10-Q
2019 Q3
Quarterly report
8 Nov 19
10-Q
2019 Q2
Quarterly report
9 Aug 19
10-Q
2019 Q1
Quarterly report
10 May 19
10-K
2018 FY
Annual report
18 Mar 19
10-Q
2018 Q3
Quarterly report
9 Nov 18
Current reports
8-K
Entry into a Material Definitive Agreement
12 Mar 21
8-K
Genesis Healthcare Announces Strategic Restructuring Steps to Strengthen Balance Sheet and Chart Path for Recovery
3 Mar 21
8-K
Genesis Healthcare Announces Leadership Change
5 Jan 21
8-K
Company Provides COVID-19 Update
9 Nov 20
8-K
Company Provides COVID-19 Update
10 Aug 20
8-K
Departure of Directors or Certain Officers
9 Jun 20
8-K
Genesis Healthcare Reports First Quarter 2020 Results
27 May 20
8-K
Other Events
8 May 20
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Apr 20
8-K
Amendments to Articles of Incorporation or Bylaws
26 Mar 20
Registration and prospectus
15-12B
Securities registration termination
25 Mar 21
25
Voluntary exchange delisting
15 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
15 May 20
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
PRE 14A
Preliminary proxy
9 Apr 20
DEFA14A
Additional proxy soliciting materials
26 Apr 19
DEF 14A
Definitive proxy
26 Apr 19
DEFA14A
Additional proxy soliciting materials
27 Apr 18
DEF 14A
Definitive proxy
27 Apr 18
DEF 14A
Definitive proxy
28 Apr 17
DEFA14A
Additional proxy soliciting materials
28 Apr 17
Other
EFFECT
Notice of effectiveness
15 Mar 21
UPLOAD
Letter from SEC
5 Nov 19
CORRESP
Correspondence with SEC
4 Nov 19
UPLOAD
Letter from SEC
24 Jan 17
CORRESP
Correspondence with SEC
20 Jan 17
CORRESP
Correspondence with SEC
4 Jan 17
UPLOAD
Letter from SEC
22 Dec 16
CORRESP
Correspondence with SEC
5 Oct 16
UPLOAD
Letter from SEC
23 Sep 16
UPLOAD
Letter from SEC
2 Aug 16
Ownership
4
JoAnne Susan Reifsnyder
28 May 21
4
Michael Scott Sherman
28 May 21
4
Stephen Scott Young
28 May 21
4
Paul David Bach
28 May 21
4
Richard Feifer
28 May 21
4
Thomas DiVittorio
28 May 21
3
Harry James Wilson
26 Mar 21
3
David Harrington
12 Mar 21
3
John Randazzo
12 Mar 21
SC 13G/A
LEBOWITZ STEVEN D
29 Jan 21